Application of the bivalent ligand approach to the design of novel dimeric serotonin reuptake inhibitors [4]

Journal of the American Chemical Society

Volumn 122, Issue 22, 2000, Pages 5393-5394

  Tamiz, Amir P ^a   Zhang, Jianrong ^a   Zhang, Mei ^b   Wang, Cheng Z ^b   Johnson, Kenneth M ^b   Kozikowski, Alan P ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; LIGAND; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; LETTER; LIGAND BINDING;

EID: 0034616880     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja000199f     Document Type: Letter

References (29)

1. Broekkamp, C. L. E.; Leysen, D.; Peeters, B. W. M. M.; Pinder, R. M. J. Med. Chem. 1995, 38, 4615-4633.
2. Frances, A.; Manning, D.; Marin, D.; Kocsis, J.; McKinney, K.; Hall, W.; Klein, M. Psychopharmacol, Suppl. 1992, 106, S82-S86.
3. Krazler, H. R.; Amine, H.; Modesto-Lowe, V.; Oncken, C. Pharmacol. Treat. Drug Alcohol Depend. 1999, 22, 401-423. Schaffer, A.; Naranjo, C. A. Drugs 1998, 56, 571-585.
4. Krazler, H. R.; Amine, H.; Modesto-Lowe, V.; Oncken, C. Pharmacol. Treat. Drug Alcohol Depend. 1999, 22, 401-423. Schaffer, A.; Naranjo, C. A. Drugs 1998, 56, 571-585.
5. Sullivan, M. J.; Reesor, K.; Mikail, S.; Fisher, R. Pain 1993, 52, 294.
6. (a) Peterson, C. B.; Mitchell, J. E. J. Clin. Psychiatry 1999, 55, 685-697.
7. (b) Kaye, W. H. Psychopharmacol. Bull. 1997, 33, 335-344.
8. Brody, A. L.; Saxena, S.; Schwartz, J. M.; Stoessel, P. W.; Maidment, K.; Phelps, M. E.; Baxter, L. R., Jr. Psychiatr. Res. 1998, 84, 1-6.
9. (a) Briner, K.; Dodel, R. C. Curr. Pharm. Disign 1998, 4, 291-302.
10. (b) Owens, M. J.; Morgan, N.; Plott, S. J.; Nemeroff, C. B. J. Pharmacol. Exp. Ther. 1997, 283, 1305-1322.
11. (c) Mongeau, R.; Blier, P.; de Montigny, C. Brain Res. Rev. 1997, 23, 145-195.
12. (a) Wong, D. T.; Bymaster, F. P.; Engleman, E. A. Life Sci. 1995, 57, 411-441.
13. (b) Robertson, D. W.; Krushinski, J. H.; Fuller, R. W.; Leander, J. D. J. Med. Chem. 1988, 31, 1412-1417.
14. Dechant, K. L.; Clissold, S. P. Drugs 1991, 41, 225-253.
15. Smith, M. P.; Hoepping, A.; Johnson, K. M.; Trzcinska, M.; Kozikowski, A. P. DDT 1999, 4, 322-332.
16. (a) Shuker, S. B.; Hajduk, P. J.; Meadows, R. P.; Fesik, S. W. Science 1996, 274, 1531-1534.
17. (b) Jencks, W. P. Proc. Natl. Acad. Sci. U.S.A. 1981, 78, 4046-4050.
18. (c) Mammen, M.; Choi, S. -K.; Whitesides, G. M. Angew. Chem. Int. Ed. 1998, 37, 2754-2794.
19. (a) Erez, M.; Takemori, A. I.; Portoghese, P. S. J. Med. Chem. 1982, 25, 847-849.
20. (b) Portoghese, P. S. J. Med. Chem. 1992, 35, 1927-1937.
21. (a) Halazy, S.; Perez, M.; Fourrier, C.; Pallard, I.; Pauwels, P. J.; Palmier, C.; Gareth, W. J.; Valentine, J.-P.; Bonnafous, R.; Martinez, J. J. Med. Chem. 1996, 39, 4920-4927.
22. (b) LeBoulluec, K. L.; Mattson, R. J.; Mahle, C. D.; McGovern, R. T.; Nowak, H. P.; Gentile, A. J. Bioorg. Med. Chem. Lett. 1995, 5, 123-126.
23. (c) Halazy, S.; Perez, M.; Fourrier, C.; Pallard, I.; Pauwels, P. J.; Palmier, C.; John, G. W.; Valentin, J-. P.; Bonnafous, R.; Martinez, J. J. Med. Chem. 1996, 39, 4920-4927.
24. (a) Kozikowski, A. P.; Araldi, G. L.; Boja, J.; Meil, W. M.; Johnson, K. M.; Flippen-Anderson, J. L.; George, C.; Saiah, E. J. Med. Chem. 1998, 41, 1962-1969.
25. (b) Tamiz, A. P.; Zhang, J.; Fliuppen-Anderson, J. L.; Zhang, M.; Johnson, K. M.; Deschaux, O.; Tella, S.; Kozikowski, A. P. J. Med. Chem. 2000, 43, 1215-1222.
26. Smith, M. P.; Johnson, K. M.; Zhang, M.; Flippen-Anderson, J. L.; Kozikowski, A. P. J. Am. Chem. Soc. 1998, 120, 9072-9073.
27. Engelsloft, M.; Hansen, J. B. Acta Chem. Scand. 1996, 50, 164-169.
28. Wang, S.; Sakamuri, S.; Enyedy, I.; Kozikowski, A. P.; Deschaux, O.; Bandyopadhyay, B. C.; Tella, S. R.; Zaman, W. A.; Johnson, K. M. J. Med. Chem. 2000, 41, 351-360.
29. Kilic, F.; Rudnick, G. Proc. Natl. Acad. Sci. U.S.A. 2000, in press.